Evidence map›Paper›PMID 31475076›Full record

ArticleACS macro letters2019

Enhancement of Macromolecular Ice Recrystallization Inhibition Activity by Exploiting Depletion Forces.

Toru Ishibe, Thomas Congdon, Christopher Stubbs, Muhammad Hasan, Gabriele C Sosso, Matthew I Gibson

Abstract read
In one paragraph

Article in ACS macro letters, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. De novo designed ice-binding proteins from twist-constrained helices.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Toru IshibeDepartment of Chemistry, Warwick Medical School, and Centre for Scientific Computing, University of Warwick Coventry, CV4 7AL, United Kingdom.
Thomas CongdonDepartment of Chemistry, Warwick Medical School, and Centre for Scientific Computing, University of Warwick Coventry, CV4 7AL, United Kingdom.
Christopher StubbsDepartment of Chemistry, Warwick Medical School, and Centre for Scientific Computing, University of Warwick Coventry, CV4 7AL, United Kingdom.
Muhammad HasanDepartment of Chemistry, Warwick Medical School, and Centre for Scientific Computing, University of Warwick Coventry, CV4 7AL, United Kingdom.
Gabriele C SossoDepartment of Chemistry, Warwick Medical School, and Centre for Scientific Computing, University of Warwick Coventry, CV4 7AL, United Kingdom.
Matthew I GibsonDepartment of Chemistry, Warwick Medical School, and Centre for Scientific Computing, University of Warwick Coventry, CV4 7AL, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antifreeze (glyco) proteins (AF(G)Ps) are potent inhibitors of ice recrystallization and may have biotechnological applications. The most potent AF(G)Ps function at concentrations a thousand times lower than synthetic mimics such as poly(vinyl alcohol), PVA. Here, we demonstrate that PVA's ice recrystallization activity can be rescued at concentrations where it does not normally function, by the addition of noninteracting polymeric depletants, due to PVA forming colloids in the concentrated saline environment present between ice crystals. These depletants shift the equilibrium toward ice binding and, hence, enable PVA to inhibit ice growth at lower concentrations. Using theory and experiments, we show this effect requires polymeric depletants, not small molecules, to enhance activity. These results increase our understanding of how to design new ice growth inhibitors, but also offer opportunities to enhance activity by exploiting depletion forces, without re-engineering ice-binding materials. It also shows that when screening for IRI activity that polymer contaminants in buffers may give rise to false positive results.

Identifiers

PMID31475076
PMCPMC6711362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.